Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C.
Di Maio VC, Barbaliscia S, Teti E, Fiorentino G, Milana M, Paolucci S, Pollicino T, Morsica G, Starace M, Bruzzone B, Gennari W, Micheli V, Yu La Rosa K, Foroghi L, Calvaruso V, Lenci I, Polilli E, Babudieri S, Aghemo A, Raimondo G, Sarmati L, Coppola N, Pasquazzi C, Baldanti F, Parruti G, Perno CF, Angelico M, Craxì A, Andreoni M, Ceccherini-Silberstein F; HCV Virology Italian Resistance Network Group (Vironet C). Di Maio VC, et al. Among authors: calvaruso v. Liver Int. 2021 Aug;41(8):1802-1814. doi: 10.1111/liv.14797. Epub 2021 Feb 8. Liver Int. 2021. PMID: 33497016
Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial.
Alaimo G, Di Marco V, Ferraro D, Di Stefano R, Porrovecchio S, D'Angelo F, Calvaruso V, Craxì A, Almasio PL. Alaimo G, et al. Among authors: calvaruso v. World J Gastroenterol. 2006 Nov 14;12(42):6861-4. doi: 10.3748/wjg.v12.i42.6861. World J Gastroenterol. 2006. PMID: 17106937 Free PMC article. Clinical Trial.
Implication of normal liver enzymes in liver disease.
Calvaruso V, Craxì A. Calvaruso V, et al. J Viral Hepat. 2009 Aug;16(8):529-36. doi: 10.1111/j.1365-2893.2009.01150.x. Epub 2009 Jul 28. J Viral Hepat. 2009. PMID: 19656288 Review.
Fibrosis in chronic viral hepatitis.
Calvaruso V, Craxì A. Calvaruso V, et al. Best Pract Res Clin Gastroenterol. 2011 Apr;25(2):219-30. doi: 10.1016/j.bpg.2011.02.012. Best Pract Res Clin Gastroenterol. 2011. PMID: 21497740 Review.
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C.
Rizzo L, Calvaruso V, Cacopardo B, Alessi N, Attanasio M, Petta S, Fatuzzo F, Montineri A, Mazzola A, L'abbate L, Nunnari G, Bronte F, Di Marco V, Craxì A, Cammà C. Rizzo L, et al. Among authors: calvaruso v. Am J Gastroenterol. 2011 Dec;106(12):2112-20. doi: 10.1038/ajg.2011.341. Epub 2011 Oct 4. Am J Gastroenterol. 2011. PMID: 21971536
IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection.
Di Marco V, Bronte F, Calvaruso V, Capra M, Borsellino Z, Maggio A, Renda MC, Pitrolo L, Lo Pinto MC, Rizzo M, Fiorenza F, Gerardi C, Grimaudo S, Di Cristina A, Levrero M, Craxì A. Di Marco V, et al. Among authors: calvaruso v. Haematologica. 2012 May;97(5):679-86. doi: 10.3324/haematol.2011.050351. Epub 2011 Dec 16. Haematologica. 2012. PMID: 22180419 Free PMC article.
Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B.
Lampertico P, Viganò M, Di Costanzo GG, Sagnelli E, Fasano M, Di Marco V, Boninsegna S, Farci P, Fargion S, Giuberti T, Iannacone C, Regep L, Massetto B, Facchetti F, Colombo M; PegBeLiver Study Group. Lampertico P, et al. Gut. 2013 Feb;62(2):290-8. doi: 10.1136/gutjnl-2011-301430. Epub 2012 Aug 2. Gut. 2013. PMID: 22859496 Clinical Trial.
143 results